Meeting
2017 Genitourinary Cancers Symposium
Impact of immune checkpoint protein expression in tumor cells and tumor infiltrating CD8+ T cells on clinical benefit from PD-1 blockade in metastatic clear cell renal cell carcinoma (mccRCC).
Authors
Jean-Christophe Pignon
Brigham and Women's Hospital, Boston, MA
Jean-Christophe Pignon , Opeyemi Jegede , Kathleen M. Mahoney , Raphael Brandao Moreira , Jesse Novak , Hilla Conen , Craig Norton , Lauren Christine Harshman , Eliezer Mendel Van Allen , Catherine J. Wu , Michael B. Atkins , Gordon J. Freeman , Paul J. Catalano , Toni K. Choueiri , David F. McDermott , Sabina Signoretti
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Penile, Urethral, and Testicular Cancers; Renal Cell Cancer
Track
Renal Cell Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 477)
DOI
10.1200/JCO.2017.35.6_suppl.477
Abstract #
477
Poster Bd #
E16
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
Evaluation of predictive biomarkers for nivolumab in metastatic clear cell renal cell carcinoma (mccRCC) using RECIST and immune-related (IR) RECIST.
First Author: Jean-Christophe Pignon
Poster
2016 ASCO Annual Meeting
Analysis of immune infiltrates in a genomically characterized clinical cohort of head and neck squamous cell carcinoma (HNSCC) patients (pts).
First Author: Nicole Grace Chau
First Author: Igor Tsaur
Poster
2024 ASCO Genitourinary Cancers Symposium
Preclinical testing of a novel PD-L1 inhibitor for the treatment of renal cell carcinoma.
First Author: Michelle Hsu